Search clinical trials for: Core Study: Deferasirox

Total 20282 results

Abbott Nutrition

Completed

Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital

Pre-term Infants

United States
Sunnybrook Health Sciences Centre
Novartis

Terminated

Azacitidine Plus Deferasirox (ICL670) in Higher Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes

Canada
Ain Shams University

Unknown

Role of Vitamin C to Augment Iron Chelation With DFP or DFX

Thalassemia Major | Iron Chelation | Vitamin c

Egypt
Balgrist University Hospital

Recruiting

Passive Cervical Range of Motion in Infants (CROMinfants)

Arthrogenic Torticollis

Switzerland
Bispebjerg Hospital

Completed

Asthma and Allergy Screening AA2000 (Cross Sectional) (AA2000)

Asthma
University of Duhok

Completed

Comparison of the Accuracy and Reliability of Measurements Made on CBCT and IOS Images With Their made-on Plaster Models.

Malocclusion

Iraq
University Hospital, Lille

Recruiting

Chemotherapy and Liver Cirrhosis in Frequently-associated Cancers (CHIMIOSE)

Neoplasms | Cirrhosis

France
Galderma R&D

Completed

Phase 3 Papulopustular Rosacea Study

Papulopustular Rosacea

United States, Canada
China Medical University Hospital

Completed

Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients

Beta-thalassemia Major
Yale University
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

ImpleMEntation of a Digital-first Care deLiverY Model for Heart Failure in Uganda (MEDLY Uganda)

Heart Failure

Uganda
Sharp HealthCare
Advanced Cooling Therapy, Inc., d/b/a Attune Medical

Completed

Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation

Covid19

United States
University of Tartu
University of Helsinki; The Estonian Health Insurance Fund

Active, not recruiting

High Polygenic Risk and Health Behavior (INTERVENE)

Cardiovascular Diseases

Estonia
University Medical Center Groningen

Recruiting

POINTING: Clinical Cohort Study of Patients With Melanoma and NSCLC Receiving Checkpoint Inhibitors (POINTING)

Melanoma | Non-Small Cell Lung Cancer

Netherlands
Haukeland University Hospital
Ullevaal University Hospital; Stiftelsen Helse og Rehabilitering

Completed

Multidisciplinary Treatment in Patients With Mild Traumatic Brain Injury

Traumatic Brain Injury With Brief Loss of Consciousness

Norway
Stanford University

Not yet recruiting

Diagnostic Accuracy of Core Stethoscope Auscultation vs. Point of Care Ultrasound in Placement of Endotracheal Tube

Intubation Complication

United States
Washington University School of Medicine
Biovica

Recruiting

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

Breast Cancer | Cancer of the Breast

United States
Postgraduate Institute of Medical Education and...

Completed

Parents Perception and Compliance With Pre Operative Fasting Instructions in Paediatric Patients

Fasting

India
University of Washington
National Institute of Mental Health (NIMH)

Completed

Depression Attention for Women Now (The DAWN Study) (DAWN)

Depressive Disorder

United States
University Hospital, Angers

Completed

Efficacy of the CARE Rule Associated With the HEART Score in Patients With Emergency Chest Pain (eCARE)

Chest Pain

France, Belgium
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Withdrawn

Positive Changes in Quality of Life of Older Cancer Patients and Their Caregivers

Unspecified Adult Solid Tumor, Protocol Specific | Psychosocial Effects of Cancer and Its Treatment
Novartis Pharmaceuticals

Completed

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

Myelodysplastic Syndromes | Fanconi Syndrome | Anemia, Aplastic | Beta-thalassemia | Anemia, Diamond-Blackfan

United States
Novartis Pharmaceuticals

Withdrawn

Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High Doses

Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
Assiut University

Completed

Intracranial Collaterals in Acute Stroke and Clinical Outcome

Collateral Circulation, Any Site

Egypt
Novartis Pharmaceuticals

Completed

Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis (MIMAS)

Iron Overload

United Kingdom, Italy, Oman, United Arab Emirates, Lebanon, Thailand, Egypt
Novartis Pharmaceuticals

Completed

Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation

Chronic Iron Overload

Austria, Italy, Greece
HaEmek Medical Center, Israel

Completed

Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox

Iron Overload | Thalassemia

Israel
Novartis Pharmaceuticals

Completed

Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Transfusional Iron Overload

Italy
Wolfson Medical Center
Hadassah Medical Organization; Tel-Aviv Sourasky Medical Center; Sheba Medical... and other collaborators

Completed

Evaluation the Effect of Exjade on Oxidative Stress in Low Risk Myelodysplastic Syndrome Patients With Iron Over Load

Myelodysplastic Syndrome

Israel
Boston Medical Center

Completed

Impact of Rapid Flu Testing in BMC ED (FluProcess)

Influenza | Influenza-Like Illness

United States
Assiut University

Not yet recruiting

10 Years Cardiovascular Risk Score Among Primary Health Care Centre Attendees, Assiut Governorate.

Cardiovascular Risk Score
University of Pittsburgh
National Cancer Institute (NCI)

Completed

Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer

Unspecified Adult Solid Tumor, Protocol Specific | Psychosocial Effects of Cancer and Its Treatment

United States
Gruppo Italiano Malattie EMatologiche dell'Adulto

Completed

Safety, Tolerability, and Efficacy of Deferasirox in MDS

Myelodysplastic Syndromes | Hemosiderosis

Italy
Novartis Pharmaceuticals

Completed

ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox

Anemia

United States
Novartis Pharmaceuticals

Completed

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Transfusional Iron Overload in β-thalassemia

United States, Greece, Argentina, Germany, Belgium, Italy, United Kingdom, France, Tunisia, Canada, Turkey, Brazil
Novartis Pharmaceuticals

Completed

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

Transfusional Iron Overload | β-thalassemia

Italy
Novartis Pharmaceuticals

Completed

A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity

Transfusional Iron Overload

United States, Greece, Italy
University of Texas Southwestern Medical Center
Novartis Pharmaceuticals

Completed

Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda

Porphyria Cutanea Tarda

United States
Novartis Pharmaceuticals

Completed

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration) (ESCALATOR)

Iron Overload | Hemosiderosis | Beta-thalassemia Major | Rare Anemia

Egypt, Oman, Saudi Arabia, Syrian Arab Republic, Lebanon
Novartis Pharmaceuticals

Completed

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

Anemia | Hemosiderosis

United States, Germany, Belgium, United Kingdom, Italy, Canada, France
Hospices Civils de Lyon

Completed

Df-Life : Quality of Life in Patients With Fibrous Dysplasia (Df-Life)

Fibrous Dysplasia

France
Fondazione Italiana Sindromi Mielodisplastiche-ETS

Terminated

Early and Low Dose Deferasirox (3.5 mg/kg FCT) to Suppress NTBI and LPI as Early Intervention to Prevent Tissue Iron Overload in Lower Risk MDS

Myelodysplastic Syndromes

Italy
Rosa Cabanas Valdés
Corporacion Parc Tauli; Institut Investigacio Sanitaria Pere Virgili

Completed

"Core Stability" Exercises to Improve Sitting Balance in Stroke Patients (Fisionet)

Stroke | Cerebrovascular Accident | Cerebral Stroke

Spain
Kaia Health Software
Brigham and Women's Hospital

Unknown

The Kaia Back Pain Intervention for Self-management of Low Back Pain (BACKSPIN)

Low Back Pain

United States
Groupe Francophone des Myelodysplasies
Novartis

Unknown

A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS (GFM-EXVD-AZA)

MDS

France, Belgium
Novartis Pharmaceuticals

Completed

Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox.

Hepatic Impairment

Germany
Novartis Pharmaceuticals

Terminated

Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study (MACS1574)

Myelodysplastic Syndrome | Transfusional Iron Overload

Spain, France, Italy, South Africa
Novartis Pharmaceuticals

Completed

This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.

Myelodysplastic Syndrome | Thalassemia

Russian Federation
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

Liver Iron Overload

Italy
VA Office of Research and Development

Not yet recruiting

CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA) (GOURMET-VA)

Heart Failure

United States
North Bristol NHS Trust
University of Sheffield; University of Bristol; Newcastle University; University... and other collaborators

Unknown

Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM)

Lower Urinary Tract Symptoms | Voiding Dysfunction | Detrusor Underactivity | Benign Prostate Obstruction

United Kingdom

Search clinical trials for: Core Study: Deferasirox

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations